EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

Completed · Phase 3 · Has a placebo group

Conditions studied: Hyperphosphatemia, Kidney Failure

In brief

The purpose of this study is to determine if calcium acetate (PhosLo) can control serum phosphorus in pre-dialysis patients with moderate to severe impairment of kidney function.

Key facts

Study ID
NCT00211978
Run by
Nabi Biopharmaceuticals
People needed
110
Starts
2005-05-01
Expected to finish
2006-10-01
Last updated by the study team
2008-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.